4 Artificial Intelligence (AI) Stocks at the Top of My Buy List for March

Azure revenue grew 39% YoY in Q2 FY2026, Broadcom's AI semiconductor sales jumped 106% to $8.4B in Q1 FY2026, and TSMC projects ~60% CAGR for AI-related chips from 2024–2029; Nvidia trades at 21.6x forward EPS vs the S&P's ~21.7x. The piece flags MSFT (~25% below its ATH), NVDA (~11% below ATH), AVGO and TSM as long-term buys tied to the AI buildout but recommends multi-year positions to capture the expected sustained growth.

Analysis

The AI spend cycle is bifurcating compute demand into training (high-performance GPUs + software stack) and large-scale inference (cost-per-inference optimized ASICs and networking). That bifurcation creates a durable duopoly dynamic: one player wins training economics via software and ecosystem lock-in, while vertically integrated/custom silicon vendors win inference pockets by extracting system-level value (networking, firmware, packaging) and compressing GPU ASPs in latency/cost-sensitive applications. Expect margin migration into systems and services around the ASIC winners rather than raw silicon alone.

Foundry and systems supply chains are the choke points that will determine winners over 12–36 months. Advanced-node allocation, substrate/interposer lead times, and power/cooling constraints give foundries and packaging specialists pricing power; but node-access concentration and geopolitics create asymmetric tail risk — a constrained node or export-policy shock would reprice the whole stack within quarters. Conversely, a capex reacceleration by hyperscalers could temporarily pull forward revenue but also create a 9–18 month inventory & margin hangover once utilization normalizes.

Primary catalysts to watch are hyperscaler purchasing cadence, guidance on model-to-inference migration, and policy/export announcements. Near-term (0–3m) moves will be earnings and order disclosures; medium-term (3–18m) outcomes hinge on capacity build and design wins; long-term (2–5y) outcomes depend on software lock-in and total cost per inference reductions. The consensus favours broad-brush exposure — the more actionable edge is allocating by supply‑chain leverage and optionality to design wins, not only headline AI beneficiaries.

Key Decisions for Investors

• AVGO — Overweight via defined-risk call spread: buy 12–18 month AVGO call (approx. 15–25% OTM) and sell a higher strike to fund ~50% of premium. Position size 2–3% NAV. Rationale: capture system-level wins (networking + ASIC integration) with capped cost; target +35–60% IRR if AVGO secures large inference design wins; downside limited to premium (stop if spread loses 60%).
• NVDA — Constructed upside with protection: buy a 9–12 month call spread (10–30% OTM) sized 1.5–2% NAV, and buy a cheap near-term (3–6m) 6–8% OTM put as tail insurance. This reduces theta and limits drawdowns; expect asymmetric upside if training demand re-accelerates, but protect for a 25–40% drawdown triggered by inventory correction or export shocks.
• TSM — Core long via LEAPs + geopolitical hedge: buy Dec‑2028 LEAP calls (1.5–2% NAV) to capture secular foundry pricing and node scarcity; fund with selling 3–6 month calls that are 8–12% OTM. Hedge with a small allocation (0.3% NAV) to short-dated puts on regional/EM tech indices or buy single-month puts on TSM to limit policy shock risk. Target 2x+ over 24 months; cut if foundry guidance shows normalized utilization for two consecutive quarters.
• MSFT — Income-enhanced long: buy 18–30 month MSFT LEAP calls (1.5–2% NAV) and sell rolling 1–3 month OTM calls to monetize carry. This preserves upside optionality to platform lock-in while generating yield; aim for 15–25% annualized return if cloud/AI SaaS monetization accelerates. Maintain a hard stop of -30% on the net option position and trim if enterprise AI adoption misses 2 consecutive quarters.